Results 81 to 90 of about 15,426 (247)

Diagnostic challenges of bronchiectasis [PDF]

, 2016
Bronchiectasis is a condition of increasing incidence and prevalence around the world. Many different diseases have been associated with bronchiectasis, and their treatment can differ widely.
Agarwal, Agusti, Andonopoulos, Anwar, Barbato, Black, Blasi, Chan, Cohen, Davis, Fenlon, Fujita, Gatheral, Goeminne, Gono, Grenier, Guillermo Suarez-Cuartin, Hurst, James D. Chalmers, Jefferis, Kartalija, King, King, King, Knowles, Knutsen, Lee, Lees, Leigh, Lonni, Mahadeva, Marthin, Martińez-García, Martínez-García, McDonnell, McShane, McShane, Menzies, Mitchell, Ni, Notarangelo, Oriol Sibila, O’Brien, Paganin, Papanikolaou, Park, Parr, Pasteur, Pasteur, Patel, Perry, Quint, Remy-Jardin, Roifman, Rosenzweig, Shah, Shoemark, Similä, Solanki, Stannard, Stockley, Swinson, Valery, Vendrell, Wilczynska   +64 more
core   +2 more sources

New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub‐Committee in 2021–2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report

Allergy, Volume 81, Issue 3, Page 684-699, March 2026.
ABSTRACT The WHO/IUIS Allergen Nomenclature Sub‐Committee is an international body of experts that maintains the systematic nomenclature of allergenic proteins by assigning official names to newly identified allergens submitted by researchers. Here, we summarize the data on new allergens approved between 2021 and 2024.
Christian Radauer, Gabriele Gadermaier, Richard E. Goodman, Alain Jacquet, Uta Jappe, Andreas L. Lopata, Anna Pomés, Monika Raulf, Keity S. Santos, Josefina Zakzuk, Yuzhu Zhang, Joana Vitte, on behalf of the WHO/IUIS Allergen Nomenclature Sub‐Committee   +12 more
wiley   +1 more source

Immunogenetics of invasive aspergillosis [PDF]

, 2017
Invasive aspergillosis is one of the most important infections in hematopoietic stem cell transplant recipients, with an incidence rate of 5-15% and an associated mortality of 30-60%. It remains unclear why certain patients develop invasive aspergillosis
Bochud, Pierre-Yves, Lamoth, Frédéric, Rubino, Ivana   +2 more
core  

IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation. [PDF]

, 2015
BACKGROUND: Single-nucleotide polymorphisms (SNPs) in immune genes have been associated with susceptibility to invasive mold infection (IMI) among hematopoietic stem cell but not solid-organ transplant (SOT) recipients.
Berger, C., Bibert, S., Bochud, P. Y., Boggian, K., Cusini, A., Garzoni, C., Gresnigt, M. S., Hirsch, H. H., Joosten, L. A., Kutalik, Z., Lecompte, T., Manuel, O., Meylan, P. R., Mueller, N. J., Pascual, M., Rueger, S., Steiger, J., Swiss Transplant Cohort Study, Stcs, Swiss Transplant Cohort, Study, van de Veerdonk, F. L., van Delden, C., Weisser, M., Wojtowicz, A.   +22 more
core   +4 more sources

Allergic Bronchopulmonary Aspergillosis Unmasked: Case Series of Varied Pulmonary Presentations [PDF]

Indian Journal of Respiratory Care
Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction to the fungus Aspergillus fumigatus, primarily affecting individuals with asthma or cystic fibrosis (CF).
Anand R, Arun Pandiyan S, Jayavignesh J, Raghul Raj S   +3 more
doaj   +1 more source

Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis [PDF]

, 2018
Bronchiectasis is a disease associated with chronic progressive and irreversible dilatation of the bronchi and is characterised by chronic infection and associated inflammation.
A Fairs, A Kumar, A Palwatwichai, A Shoemark, AA Zaid, AB Chang, AC Yii, AE Seitz, AF Barker, AM Li, AT Bom, C Castelo-Branco, CB Wilson, D Menzies, DF Wurzel, DM Becroft, DP Steinfort, EA Edwards, ED Bateman, FC Ringshausen, FC Ringshausen, G Davies, G Gavazzi, G Sanchez-Munoz, GA Anwar, GB Rogers, GB Rogers, GB Rogers, GB Rogers, GB Rogers, H Kunst, HJ Kwak, J Angrill, J Birch, J Bongaarts, J Park, J Twiss, James D. Chalmers, JK Fleshman, JK Quint, JM Leung, K Dimakou, K Kvell, KA Munro, KF Woolnough, KJ Goh, KM Eastham, KM Hare, KS Brower, KW Tsang, L Das, L Einsiedel, L Maiz, LD Nguyen, LW Chen, M Al-Alawi, M Buscot, M Chan-Yeung, M Kikawada, M Lehmann, M Mirsaeidi, M Mirsaeidi, M Monteagudo, M Rojas, M Volkova, M Wickremasinghe, MA Ghannoum, MA Murray, MB Nicotra, MC Pasteur, Micheál Mac Aogáin, MJ Cox, MJ McDonnell, MJ McDonnell, MM Tunney, MR Loebinger, MW Rytel, N Kapur, N Kapur, O Saynajakangas, O Saynajakangas, O Sibila, P Purcell, PC Goeminne, PC Goeminne, PJ Cole, PJ Linton, PJ Marostica, PJ McShane, PL Ho, PT King, PT King, PT King, Q Qi, R Krause, R Singleton, Ravishankar Chandrasekaran, RJ Boyton, RJ Singleton, RM Duff, S Aliberti, S Bibby, S Borekci, S Finch, S Honarbakhsh, SA Evans, Sanjay H. Chotirmall, SH Chotirmall, SH Chotirmall, SH Chotirmall, SH Chotirmall, SH Chotirmall, SJ Fowler, ST Kim, Stuart J. Elborn, T Kadowaki, T Kovesi, TR Aksamit, TR Aksamit, V Goyal, WJ Guan, WJ Guan, WJ Guan, YH Gao, Z Zoumot   +124 more
core   +2 more sources

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

Clinical and Experimental Neuroimmunology, Volume 17, Issue 1, February 2026.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa, Ema Rodrigues, Hiroyuki Murai   +2 more
wiley   +1 more source

Unique presentations and chronic complications in adult cystic fibrosis: do they teach us anything about CFTR? [PDF]

, 2000
The increase in numbers of adults with cystic fibrosis (CF) has allowed us to identify previously unrecognized chronic complications of CF, as well as appreciate unique presentations of cystic fibrosis-related diseases. Do these chronic complications and
Cystic Fibrosis Foundation, JP Neglia, CD Sheldon, GJ Tsongalis, FJ Tedesco, JC McIntosh, RA Padua, RJ Stead, LE Kopito, M Couce, SP Conway, DS Donovan Jr, RL Jilka, LK Bachrach, M Claustres, JE Mickle, R Gervais, JA Cohn, MP Boyle, X Wang, KJ Friedman, T Casals, PW Miller, C Bombieri   +23 more
core   +2 more sources

A Role for Non‐Canonical Caspases in Fungal Allergic Airway Disease

Clinical &Experimental Allergy, EarlyView.
Thomas J. Williams, Nazanin Zounemat Kermani, Luis E. Gonzales‐Huerta, Anand Shah, Ian M. Addcock, Kian Fan Chung, Darius Armstrong‐James, U‐BIORPED Study Group   +7 more
wiley   +1 more source

Aspergillus Serology Predicts Relapse in Chronic Pulmonary Aspergillosis: Implications for Personalised Follow‐Up Strategies

Mycoses, Volume 69, Issue 2, February 2026.
ABSTRACT Introduction Relapses occur in up to 40% of patients after prolonged courses of antifungal treatment for chronic pulmonary aspergillosis (CPA). The factors predisposing to relapse remain poorly defined. Methods We conducted a retrospective study of adults treated for ≥ 6 months with oral azoles for CPA.
Annabel Choyce, Stefano Colombo, Cyrin Cyriac, Abdulrazaq Alasfour, Wai Kien Ng, Lauren Amphlett, Chris Kosmidis   +6 more
wiley   +1 more source